The need for access to anti-TB drugs in India: An interview with Anand Grover

The need for access to anti-TB drugs in India: An interview with Anand Grover

Grover appeared for TB survivors Nandita Venatesan and Phumeza Tisile before the Assistant Controller of Patents and Designs, and also argued a public interest litigation filed at the Bombay High Court by TB survivors Mira Yadav and Brinelle D’Souza, for the issue of compulsory licences on TB medication Bedaquiline and Delamanid.
Published on
Loading content, please wait...
The Leaflet
theleaflet.in